Valiant Laborato

{
  "main_header": {
    "sid": 10039033,
    "name": "Valiant Laborato",
    "stock_name": "Valiant Laborato",
    "full_name": "Valiant Laboratories Ltd",
    "name_url": "stocks-analysis/valiant-laborato",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "61.69",
    "chg": -3.02,
    "chgp": "-4.67%",
    "dir": -1,
    "prev_price": "64.71",
    "mcapval": "351.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543998,
    "symbol": "VALIANTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0JWS01017",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "1.18 lacs",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/valiant-laborato-10039033-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.63.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-falls-to-52-week-low-of-rs6305-3794492",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_priceRelatedfactors_3794492.png",
        "date": "2026-01-19 10:42:01",
        "description": "Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.63.05, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors."
      },
      {
        "title": "Valiant Laboratories Ltd Stock Hits All-Time Low Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-hits-all-time-low-amidst-prolonged-downtrend-3794467",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_priceRelatedfactors_3794467.png",
        "date": "2026-01-19 10:33:54",
        "description": "Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new all-time low of Rs.63.05, marking a significant milestone in its ongoing decline. The stock’s performance continues to lag behind key market indices and sector benchmarks, reflecting persistent pressures on its valuation and financial metrics."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3791793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_mojoScore_3791793.png",
        "date": "2026-01-14 10:10:37",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Valiant Laboratories Ltd Falls to 52-Week Low of Rs.63.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-falls-to-52-week-low-of-rs6345-3791605",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_priceRelatedfactors_3791605.png",
        "date": "2026-01-14 09:58:46",
        "description": "Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.63.45 today, marking a significant decline in its stock price amid broader market movements and company-specific performance factors."
      },
      {
        "title": "Valiant Laboratories Ltd Stock Hits All-Time Low Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-hits-all-time-low-amidst-prolonged-downtrend-3791531",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_priceRelatedfactors_3791531.png",
        "date": "2026-01-14 09:34:15",
        "description": "Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new all-time low of Rs.63.45, marking a significant milestone in its ongoing decline. The stock’s recent performance reflects a sustained period of underperformance relative to both its sector and broader market indices."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3779916",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_mojoScore_3779916.png",
        "date": "2026-01-03 10:10:34",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Valiant Laborato Sees Revision in Market Assessment Amid Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laborato-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3766972",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantLaborato_mojoScore_3766972.png",
        "date": "2025-12-23 10:10:29",
        "description": "Valiant Laborato, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent adjustment highlights shifts in key analytical parameters that investors should consider amid the company’s subdued performance and valuation concerns."
      },
      {
        "title": "Valiant Laboratories Stock Falls to 52-Week Low of Rs 63.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-stock-falls-to-52-week-low-of-rs-635-3761390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantLaborato_priceRelatedfactors_3761390.png",
        "date": "2025-12-17 13:34:04",
        "description": "Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs 63.5, marking a significant price level for the stock amid broader market fluctuations."
      },
      {
        "title": "Valiant Laboratories Stock Hits All-Time Low Amidst Prolonged Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-stock-hits-all-time-low-amidst-prolonged-downtrend-3761352",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantLaborato_priceRelatedfactors_3761352.png",
        "date": "2025-12-17 12:48:20",
        "description": "Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached an all-time low in its stock price, reflecting a sustained period of underwhelming market performance and financial metrics that highlight ongoing difficulties within the company’s operations and valuation."
      }
    ],
    "total": 272,
    "sid": "10039033",
    "stock_news_url": "https://www.marketsmojo.com/news/valiant-laboratories-10039033"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Laboratories Ltd has announced <strong>1:4</strong> rights issue, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.63.05

2026-01-19 10:42:01

Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.63.05, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors.

Read full news article

Valiant Laboratories Ltd Stock Hits All-Time Low Amidst Prolonged Downtrend

2026-01-19 10:33:54

Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new all-time low of Rs.63.05, marking a significant milestone in its ongoing decline. The stock’s performance continues to lag behind key market indices and sector benchmarks, reflecting persistent pressures on its valuation and financial metrics.

Read full news article

Valiant Laboratories Ltd is Rated Strong Sell

2026-01-14 10:10:37

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Valiant Laboratories Ltd Falls to 52-Week Low of Rs.63.45

2026-01-14 09:58:46

Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.63.45 today, marking a significant decline in its stock price amid broader market movements and company-specific performance factors.

Read full news article

Valiant Laboratories Ltd Stock Hits All-Time Low Amidst Prolonged Downtrend

2026-01-14 09:34:15

Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new all-time low of Rs.63.45, marking a significant milestone in its ongoing decline. The stock’s recent performance reflects a sustained period of underperformance relative to both its sector and broader market indices.

Read full news article

Valiant Laboratories Ltd is Rated Strong Sell

2026-01-03 10:10:34

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Valiant Laborato Sees Revision in Market Assessment Amid Challenging Fundamentals

2025-12-23 10:10:29

Valiant Laborato, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent adjustment highlights shifts in key analytical parameters that investors should consider amid the company’s subdued performance and valuation concerns.

Read full news article

Valiant Laboratories Stock Falls to 52-Week Low of Rs 63.5

2025-12-17 13:34:04

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs 63.5, marking a significant price level for the stock amid broader market fluctuations.

Read full news article

Valiant Laboratories Stock Hits All-Time Low Amidst Prolonged Underperformance

2025-12-17 12:48:20

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached an all-time low in its stock price, reflecting a sustained period of underwhelming market performance and financial metrics that highlight ongoing difficulties within the company’s operations and valuation.

Read full news article

View All News